Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham S Jackson

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Human Mutation|June 29, 2010
PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion UnitJon A Beck, Mark Poulter, Tracy A Campbell, et al.
Plos One|March 12, 2010
Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS)James C Stevens, Ruth Chia, William T Hendriks, et al.
Journal of Molecular Biology|February 14, 2006
Elongated oligomers assemble into mammalian PrP amyloid fibrilsM Howard Tattum, Sara Cohen-Krausz, Kanjana Thumanu, et al.
The Journal of Biological Chemistry|April 13, 2010
The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron diseaseAli Morsi El-Kadi, Virginie Bros-Facer, Wenhan Deng, et al.
JAMA Neurology|March 5, 2014
Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility studyGraham S Jackson, Jesse Burk-Rafel, Julie Ann Edgeworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Molecular Cell|May 1, 2007
Disease-associated prion protein oligomers inhibit the 26S proteasomeMark Kristiansen, Pelagia Deriziotis, Derek E Dimcheff, et al.
Communications Biology|July 31, 2020
Structural effects of the highly protective V127 polymorphism on human prion proteinLaszlo L P Hosszu, Rebecca Conners, Daljit Sangar, et al.
Molecular Psychiatry|March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesAndrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Human Mutation|June 29, 2010
PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion UnitJon A Beck, Mark Poulter, Tracy A Campbell, et al.
Plos One|March 12, 2010
Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS)James C Stevens, Ruth Chia, William T Hendriks, et al.
Journal of Molecular Biology|February 14, 2006
Elongated oligomers assemble into mammalian PrP amyloid fibrilsM Howard Tattum, Sara Cohen-Krausz, Kanjana Thumanu, et al.
The Journal of Biological Chemistry|April 13, 2010
The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron diseaseAli Morsi El-Kadi, Virginie Bros-Facer, Wenhan Deng, et al.
JAMA Neurology|March 5, 2014
Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility studyGraham S Jackson, Jesse Burk-Rafel, Julie Ann Edgeworth, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Molecular Cell|May 1, 2007
Disease-associated prion protein oligomers inhibit the 26S proteasomeMark Kristiansen, Pelagia Deriziotis, Derek E Dimcheff, et al.
Communications Biology|July 31, 2020
Structural effects of the highly protective V127 polymorphism on human prion proteinLaszlo L P Hosszu, Rebecca Conners, Daljit Sangar, et al.
Molecular Psychiatry|March 6, 2021
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseasesAndrew G B Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Pageof 6